Russell SJ - Search Results

1

Oncolytic Viruses as Antigen-Agnostic Cancer Vaccines.

Russell SJ, Barber GN. Russell SJ, et al. Cancer Cell. 2018 Apr 9;33(4):599-605. doi: 10.1016/j.ccell.2018.03.011. Cancer Cell. 2018. PMID: 29634947 Free PMC article. Review.

2

Cancer gene therapy clinical trials: lessons for the future.

Galanis E, Russell S. Galanis E, et al. Br J Cancer. 2001 Nov 16;85(10):1432-6. doi: 10.1054/bjoc.2001.2129. Br J Cancer. 2001. PMID: 11720424 Free PMC article. Review. No abstract available.

3

Oncolytic measles viruses for cancer therapy.

Nakamura T, Russell SJ. Nakamura T, et al. Among authors: russell sj. Expert Opin Biol Ther. 2004 Oct;4(10):1685-92. doi: 10.1517/14712598.4.10.1685. Expert Opin Biol Ther. 2004. PMID: 15461580 Review.

4

Oncolytic activities of approved mumps and measles vaccines for therapy of ovarian cancer.

Myers R, Greiner S, Harvey M, Soeffker D, Frenzke M, Abraham K, Shaw A, Rozenblatt S, Federspiel MJ, Russell SJ, Peng KW. Myers R, et al. Among authors: russell sj. Cancer Gene Ther. 2005 Jul;12(7):593-9. doi: 10.1038/sj.cgt.7700823. Cancer Gene Ther. 2005. PMID: 15746945

5

Pharmacokinetics of oncolytic measles virotherapy: eventual equilibrium between virus and tumor in an ovarian cancer xenograft model.

Peng KW, Hadac EM, Anderson BD, Myers R, Harvey M, Greiner SM, Soeffker D, Federspiel MJ, Russell SJ. Peng KW, et al. Among authors: russell sj. Cancer Gene Ther. 2006 Aug;13(8):732-8. doi: 10.1038/sj.cgt.7700948. Epub 2006 Mar 10. Cancer Gene Ther. 2006. PMID: 16543921

6

Dual therapy of ovarian cancer using measles viruses expressing carcinoembryonic antigen and sodium iodide symporter.

Hasegawa K, Pham L, O'Connor MK, Federspiel MJ, Russell SJ, Peng KW. Hasegawa K, et al. Among authors: russell sj. Clin Cancer Res. 2006 Mar 15;12(6):1868-75. doi: 10.1158/1078-0432.CCR-05-1803. Clin Cancer Res. 2006. PMID: 16551872

7

A measles virus vaccine strain derivative as a novel oncolytic agent against breast cancer.

McDonald CJ, Erlichman C, Ingle JN, Rosales GA, Allen C, Greiner SM, Harvey ME, Zollman PJ, Russell SJ, Galanis E. McDonald CJ, et al. Among authors: russell sj. Breast Cancer Res Treat. 2006 Sep;99(2):177-84. doi: 10.1007/s10549-006-9200-5. Epub 2006 Apr 27. Breast Cancer Res Treat. 2006. PMID: 16642271

8

Infected cell carriers: a new strategy for systemic delivery of oncolytic measles viruses in cancer virotherapy.

Iankov ID, Blechacz B, Liu C, Schmeckpeper JD, Tarara JE, Federspiel MJ, Caplice N, Russell SJ. Iankov ID, et al. Among authors: russell sj. Mol Ther. 2007 Jan;15(1):114-22. doi: 10.1038/sj.mt.6300020. Mol Ther. 2007. PMID: 17164782 Free article.

9

History of oncolytic viruses: genesis to genetic engineering.

Kelly E, Russell SJ. Kelly E, et al. Among authors: russell sj. Mol Ther. 2007 Apr;15(4):651-9. doi: 10.1038/sj.mt.6300108. Epub 2007 Feb 13. Mol Ther. 2007. PMID: 17299401 Free article. Review.

10

Viruses as anticancer drugs.

Russell SJ, Peng KW. Russell SJ, et al. Trends Pharmacol Sci. 2007 Jul;28(7):326-33. doi: 10.1016/j.tips.2007.05.005. Epub 2007 Jun 18. Trends Pharmacol Sci. 2007. PMID: 17573126 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

637 results

Search Page